Start Date
October 31, 1999
Study Completion Date
September 30, 2001
gemcitabine hydrochloride
tacedinaline
Sinai Hospital of Baltimore, Baltimore
Northern Virginia Oncology Group, Fairfax
Raleigh Hematology/Oncology Associates - Wake Practice, Raleigh
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Sarah Cannon-Minnie Pearl Cancer Center, Nashville
West Clinic, P.C., Memphis
Jewish Hospital of Cincinnati, Inc., Cincinnati
William Beaumont Hospital, Royal Oak
Tyler Cancer Center, Tyler
Cedars-Sinai Comprehensive Cancer Center, Los Angeles
Ireland Cancer Center, Cleveland
St. Boniface General Hospital, Winnipeg
Nova Scotia Cancer Centre, Halifax
Cancer Care Ontario-London Regional Cancer Centre, London
Ottawa Regional Cancer Center - General Division, Ottawa
Centre Hospitalier de l'Universite de Montreal, Montreal
Lead Sponsor
Pfizer
INDUSTRY